UA121358C2 - Інактивована стафілококова рідка вакцина, спосіб її виготовлення і спосіб лікування та профілактики нею - Google Patents
Інактивована стафілококова рідка вакцина, спосіб її виготовлення і спосіб лікування та профілактики нею Download PDFInfo
- Publication number
- UA121358C2 UA121358C2 UAA201812970A UAA201812970A UA121358C2 UA 121358 C2 UA121358 C2 UA 121358C2 UA A201812970 A UAA201812970 A UA A201812970A UA A201812970 A UAA201812970 A UA A201812970A UA 121358 C2 UA121358 C2 UA 121358C2
- Authority
- UA
- Ukraine
- Prior art keywords
- vaccine
- staphylococcal
- registration number
- strains
- deposited under
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 104
- 238000000034 method Methods 0.000 title claims abstract description 38
- 239000007788 liquid Substances 0.000 title claims abstract description 27
- 238000011282 treatment Methods 0.000 title claims description 48
- 230000002265 prevention Effects 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 5
- 241000295644 Staphylococcaceae Species 0.000 claims abstract description 20
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 18
- 206010041925 Staphylococcal infections Diseases 0.000 claims abstract description 14
- 235000015097 nutrients Nutrition 0.000 claims abstract description 14
- 230000001580 bacterial effect Effects 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 241000191940 Staphylococcus Species 0.000 claims abstract description 11
- 230000000721 bacterilogical effect Effects 0.000 claims abstract description 10
- 239000007787 solid Substances 0.000 claims abstract description 7
- 230000002949 hemolytic effect Effects 0.000 claims abstract description 6
- 210000000056 organ Anatomy 0.000 claims abstract description 6
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 4
- 230000009885 systemic effect Effects 0.000 claims abstract description 3
- 238000002347 injection Methods 0.000 claims description 47
- 239000007924 injection Substances 0.000 claims description 47
- 230000003053 immunization Effects 0.000 claims description 25
- 238000002649 immunization Methods 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 14
- 230000000813 microbial effect Effects 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 11
- 238000002255 vaccination Methods 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 9
- 238000005119 centrifugation Methods 0.000 claims description 6
- 210000004400 mucous membrane Anatomy 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 5
- 239000008272 agar Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000002028 Biomass Substances 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 230000001698 pyrogenic effect Effects 0.000 claims description 4
- 239000013049 sediment Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000008215 water for injection Substances 0.000 claims description 4
- 230000037396 body weight Effects 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 230000036512 infertility Effects 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 210000001991 scapula Anatomy 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 241000894007 species Species 0.000 abstract description 4
- 241000191984 Staphylococcus haemolyticus Species 0.000 abstract 4
- 229940037649 staphylococcus haemolyticus Drugs 0.000 abstract 4
- 241000191963 Staphylococcus epidermidis Species 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 14
- 239000003053 toxin Substances 0.000 description 11
- 231100000765 toxin Toxicity 0.000 description 11
- 108700012359 toxins Proteins 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 238000012770 revaccination Methods 0.000 description 10
- 206010020751 Hypersensitivity Diseases 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 206010017553 Furuncle Diseases 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- 230000007012 clinical effect Effects 0.000 description 5
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 4
- 208000003512 furunculosis Diseases 0.000 description 4
- SGNXVBOIDPPRJJ-PSASIEDQSA-N 1-[(1r,6r)-9-azabicyclo[4.2.1]non-4-en-5-yl]ethanone Chemical compound CC(=O)C1=CCC[C@@H]2CC[C@H]1N2 SGNXVBOIDPPRJJ-PSASIEDQSA-N 0.000 description 3
- 208000030090 Acute Disease Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010031252 Osteomyelitis Diseases 0.000 description 3
- 208000006311 Pyoderma Diseases 0.000 description 3
- 206010044302 Tracheitis Diseases 0.000 description 3
- 239000003948 anatoxin Substances 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000002557 hidradenitis Diseases 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 208000027866 inflammatory disease Diseases 0.000 description 3
- 201000009837 laryngotracheitis Diseases 0.000 description 3
- 210000001989 nasopharynx Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010034016 Paronychia Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 231100000776 exotoxin Toxicity 0.000 description 2
- 239000002095 exotoxin Substances 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000000774 hypoallergenic effect Effects 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 229940031572 toxoid vaccine Drugs 0.000 description 2
- UPCOSYBELNEQAU-UHFFFAOYSA-L (2-decoxy-2-oxoethyl)-[2-[(2-decoxy-2-oxoethyl)-dimethylazaniumyl]ethyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCOC(=O)C[N+](C)(C)CC[N+](C)(C)CC(=O)OCCCCCCCCCC UPCOSYBELNEQAU-UHFFFAOYSA-L 0.000 description 1
- 206010053555 Arthritis bacterial Diseases 0.000 description 1
- 206010004142 Bartholinitis Diseases 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010028885 Necrotising fasciitis Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000031858 Periproctitis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010057970 Toxic skin eruption Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000008073 immune recognition Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229940031348 multivalent vaccine Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201812970A UA121358C2 (uk) | 2018-12-27 | 2018-12-27 | Інактивована стафілококова рідка вакцина, спосіб її виготовлення і спосіб лікування та профілактики нею |
| PCT/UA2019/000162 WO2020139308A1 (ru) | 2018-12-27 | 2019-12-27 | Инактивированная стафилококковая жидкая вакцина |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201812970A UA121358C2 (uk) | 2018-12-27 | 2018-12-27 | Інактивована стафілококова рідка вакцина, спосіб її виготовлення і спосіб лікування та профілактики нею |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA121358C2 true UA121358C2 (uk) | 2020-05-12 |
Family
ID=71116114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201812970A UA121358C2 (uk) | 2018-12-27 | 2018-12-27 | Інактивована стафілококова рідка вакцина, спосіб її виготовлення і спосіб лікування та профілактики нею |
Country Status (2)
| Country | Link |
|---|---|
| UA (1) | UA121358C2 (ru) |
| WO (1) | WO2020139308A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115105588B (zh) * | 2021-03-23 | 2024-03-15 | 成都威斯克生物医药有限公司 | 一种金黄色葡萄球菌疫苗的生产方法及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501198B2 (en) * | 2004-06-07 | 2013-08-06 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| RU2421240C1 (ru) * | 2009-09-29 | 2011-06-20 | Государственное научное учреждение Самарская научно-исследовательская ветеринарная станция Российской академии сельскохозяйственных наук | Способ получения стафилококковой вакцины |
-
2018
- 2018-12-27 UA UAA201812970A patent/UA121358C2/uk unknown
-
2019
- 2019-12-27 WO PCT/UA2019/000162 patent/WO2020139308A1/ru active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020139308A1 (ru) | 2020-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shwartzman | Studies on Bacillus Typhosus Toxic Substances: I. Phenomenon of Local Skin Reactivity to B. Typhosus Culture Filtrate. | |
| Sabin | The filtrable microörganisms of the pleuropneumonia group | |
| CN108992667A (zh) | 一种带状疱疹疫苗及其制备方法、应用 | |
| CN101475626B (zh) | 一种从猪脾脏中提取转移因子的方法 | |
| JPS61502334A (ja) | 細胞表面蛋白質とその製法及びその使用法 | |
| US20220267419A1 (en) | Human Immunoglobulin Against Methicillin-Resistant Staphylococcus Aureus, Preparation Method Therefor, And Use Thereof | |
| JPS6160618A (ja) | 尿路感染症治療用ワクチン | |
| AU9220598A (en) | Vaginal suppository vaccine for urogenital infections | |
| UA121358C2 (uk) | Інактивована стафілококова рідка вакцина, спосіб її виготовлення і спосіб лікування та профілактики нею | |
| UA126440C2 (uk) | Полівалентна комбінована інактивована рідка вакцина проти збудників бактеріальних і грибкових захворювань сечостатевої системи, спосіб її виготовлення і спосіб лікування та профілактики нею | |
| SU997599A3 (ru) | Способ получени гетеровакцины дл лечени синдрома трихомонада | |
| WO2020139314A1 (ru) | Противобактериальная поливалентная комбинированная инактивированная жидкая вакцина | |
| CN110559436A (zh) | 卵黄抗体组合物及其在制备防治胃肠道疾病产品中的应用 | |
| UA125385C2 (uk) | Псевдомонадна інактивована рідка вакцина проти синьогнійної палички, спосіб її отримання і спосіб лікування та профілактики нею | |
| RU2602692C1 (ru) | Способ лечения хронического фарингита | |
| WO2020139312A1 (ru) | Клебсиелезно-протейная вакцина «клепропримавак» против клебсиеллы и протея | |
| RU2386448C2 (ru) | Способ получения ассоциированной анатоксин-вакцины для профилактики и лечения гнойно-септических болезней | |
| CN114146171B (zh) | 一种猪萎缩性鼻炎灭活疫苗及其制备方法 | |
| UA125851C2 (uk) | Стрептококова інактивована рідка вакцина проти стрептококів і стафілококів, спосіб її виготовлення та спосіб лікування і профілактики нею | |
| EA029938B1 (ru) | Вакцина против мыта лошадей | |
| UA125901C2 (uk) | Ешерихіозно-ентерококова інактивована рідка вакцина проти кишкової палички та ентерокока, спосіб її виготовлення та спосіб лікування і профілактики нею | |
| RU2098127C1 (ru) | Ассоциированная вакцина "нековак" против некробактериоза крупного рогатого скота | |
| RU2189252C2 (ru) | Способ получения стрептококкового анатоксина | |
| CN116751723A (zh) | 一种牛支原体菌株及其灭活疫苗和应用 | |
| Esslinger et al. | Hyaluronic-acid mediated adhesion of Pasteurella multocida to HeLa cells |